MedTrace Logo

MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of Relapse

NCT06000306 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 192

Last updated 2023-08-22

No results posted yet for this study

Summary

A study on the Effectiveness of digital droplet PCR in monitoring measurable residual disease during the early period after allogeneic hematopoietic stem cell transplantation to predict patients at high risk of relapse

Conditions

  • Measurable Residual Disease

Interventions

DIAGNOSTIC_TEST

Digital Droplet PCR

Measurable residual disease Monitoring by Digital Droplet PCR in the Early Posttransplant Period

Sponsors & Collaborators

  • Zhejiang University

    lead OTHER

Eligibility

Min Age
12 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2021-08-31
Completion
2023-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06000306 on ClinicalTrials.gov